RPG Life Sciences of the RPG Group has signed an agreement to acquire seven prescription brands from Sun Pharmaceuticals Industries for Rs 41 crore. The agreement is in line with company’s strategy to focus on formulations business. The acquired brands are primarily in respiratory and urology segments.
In addition to this, three products will complement the company’s existing range. The deal is subject to approval by the Competition Commission of India (CCI).
RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research based, pharmaceutical company, producing a wide range of quality, affordable medicines. Its brands are highly trusted by healthcare professionals and patients.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1535.35 |
Dr. Reddys Lab | 5869.15 |
Cipla | 1421.55 |
Zydus Lifesciences | 1009.15 |
Lupin | 1663.25 |
View more.. |